We are predominantly involved in business-to-business transactions. This constitutes part of our role as a supplier of goods that are used to manufacture final products for the pharma, biotech and nutrition markets. We work to ensure that our products are fit for purpose and can be used by customers safely for their intended purpose. Our customers are generally formulators who also have procedures and specialists to assess hazards and risks as well as promote the safety of their products. However, we believe that our responsibilities include providing the foundation and data for the safe use of our customers’ products.
The safe handling, use and transportation of our products lie in the hands of competent specialists. These experts assess our products on the basis of their bio- and eco-toxicological properties and their physico-chemical properties and derive the appropriate measures within the applicable legal framework. A prerequisite of successful product launches in today's demanding markets is the on-deadline compliance with all statutory requirements like notification, registration, labeling and dissemination of material safety data sheets. Comprehensive and timely information for internal and external customers and for the authorities is a business condition.
REACH - the European Chemicals Policy
REACH is the European Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals. REACH is an ongoing effort, and we will continue to strive to comply with its requirements.
Global product strategy
The International Council of Chemical Associations (ICCA) launched the Global Product Strategy (GPS) in 2006 to enhance the proper handling of chemicals throughout lifecycle and make the relevant safety information accessible to all in the form of safety summaries. These contain basic information for safe handling of chemical products, in a general, understandable language. For more information on GPS, please refer to the ICCA website and to the GPS Chemicals Portal.
In order to ensure the safe handling and use of products, regulatory authorities in many countries require tests, some of which require animal testing. Whenever possible Lonza uses validated alternatives to animal tests, and we cooperate with independent contract laboratories that are carefully selected to ensure they meet the highest ethical and quality standards.
We are developing non-animal alternatives to the use of animal testing. Examples are the Bioscience Solutions primary cell and media product lines, which represent one of the major alternatives to animal models in R&D labs.